SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-026068
Filing Date
2022-04-28
Accepted
2022-04-28 19:07:46
Documents
1
Period of Report
2022-04-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4013
  Complete submission text file 0001209191-22-026068.txt   5400
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Issuer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O EVOKE PHARMA, INC. 505 LOMAS SANTA FE DRIVE SOLANA BEACH CA 92075
Business Address
Brady Todd C (Reporting) CIK: 0001579179 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36075 | Film No.: 22869067